Recently, the State Administration of Traditional Chinese Medicine issued the "Guidelines for Home-based Traditional Chinese Medicine Intervention for People Infected with COVID-19", in which Lianhua Qingwen Capsules (Granules) are recommended. It is reported that Lianhua Qingwen is a representative Chinese patent medicine developed under the guidance of the theory of collateral diseases of traditional Chinese medicine for the treatment of viral respiratory infectious diseases. It plays an important role in the prevention and control of epidemics such as SARS, H1N1 influenza, and COVID-19.
As one of the "Three Prescriptions and Three Medicines" that are the country's major achievements in traditional Chinese medicine, Lianhua Qingwen is included in the National Health Commission's "Diagnosis and Treatment Plan for Novel Coronavirus Pneumonia" (Trial version 4 to 9) as a recommended drug. , In the current "New Coronavirus Pneumonia Diagnosis and Treatment Plan (Trial Ninth Edition)", Lianhua Qingwen is listed as a new coronavirus pneumonia medical observation html phase 2, mild, and general treatment drug. In the nearly 20 years since its launch, Lianhua Qingwen has been used by more than 1.1 billion people, playing an active role in the prevention and control of the new coronavirus epidemic in my country and the world. Because of its wide application, safe medication, and accurate efficacy, Lianhua Qingwen, which treats colds, flu, and COVID-19, has become a common medicine in Chinese families.
Lianhua Qingwen is guided by the theory of collateral diseases of traditional Chinese medicine and integrates ancient prescriptions from three dynasties.
Lianhua Qingwen is guided by the theory of collateral diseases of traditional Chinese medicine. Based on the pathogenesis characteristics of "epidemic virus attacks the lungs and stagnates the lung collaterals", the prescription principle is "clearing the plague and detoxifying, releasing the lungs and releasing heat".
The comprehensive prescription brings together two thousand years of experience in the use of traditional Chinese medicine in fighting epidemic diseases. It is based on Zhang Zhongjing's "Treatise on Febrile and Miscellaneous Diseases" of Maxing Shigan Decoction in the Eastern Han Dynasty and "Yinqiao Powder" of Wu Jutong in the Qing Dynasty. The formula is composed of 13 medicinal materials, including Isatis root , Mianma Guanzhong , Houttuynia cordata to enhance the effect of clearing away heat and detoxification, Patchouli to aromatize dampness and protect the spleen and stomach, Rhodiola rosea to improve immunity and strengthen righteousness. It integrates ancient prescriptions from three dynasties to eliminate evil and strengthen the body, which reflects the characteristics of the active intervention formula.
Because Lianhua Qingwen targets the symptoms of exogenous fever such as fever, cough, nasal congestion and runny nose, sore throat, fatigue, muscle aches, etc., multiple targets work together to exert antibacterial, anti-inflammatory, antiviral, cough and asthma relief, and enhance the body's immunity. Therefore, for colds, flu, COVID-19 and other diseases with the above clinical symptoms, Lianhua Qingwen can be used under the advice of a doctor. Early intervention and treatment will have better results.
After many verifications, the formula is safe.
Maxing Shigan Decoction has been created since Zhang Zhongjing's "Treatise on Febrile Diseases" in the Han Dynasty. Later, it became a representative prescription for clearing lung heat by later generations of doctors and is still used today. According to the "Meta-Analysis of the Efficacy and Safety of Modified and Subtracted Maxing Shigan Decoction in the Treatment of Elderly Pneumonia" published in "Guangming Traditional Chinese Medicine", the Meta analysis including 765 subjects showed that the application of Maxing Shigan Decoction is safe. Yinqiao Powder originated from Wu Jutong's Treatise on Febrile Diseases in the Qing Dynasty. It has good effects in clearing away external evils. The "Meta-Analysis of the Clinical Efficacy of Yinqiao Powder in the Treatment of Pneumonia" published by the "Journal of Guiyang College of Traditional Chinese Medicine" included 848 subjects. The Meta-analysis showed that the combined use of Yinqiao Powder is more effective than Western medicine alone, and while improving the corresponding indicators, the adverse reactions are significantly lower than the use of Western medicine alone.
searched CNKI and found 991 research documents related to Yinqiao Powder from January 1999 to March 2020. The analysis showed that the association strength of the combination with Maxing Shigan Decoction is getting stronger and continues to this day, becoming a research hotspot and new trend in the field of viral respiratory diseases. Maxing Shigan Decoction is also a prescription recommended in the diagnosis and treatment plan of new coronavirus pneumonia in the country, provinces and cities. The combined use of Maxing Shigan Decoction and Yinqiao Powder is more conducive to improving clinical treatment effects, improving patients' clinical symptoms, and making clinical medication safe. The combined use of the two can promote disease recovery and reduce adverse reactions.
Relevant classic prescriptions have been used for thousands of years, and are safe and reliable.
The rhubarb in Lianhua Qingwen draws on the clinical experience of Wu You in the Ming Dynasty who can treat plague and make good use of rhubarb to relieve the bowels and lungs. Studies have shown that Rhodiola rosea has been used as medicine since the Southern Song Dynasty. It plays a role in clearing the lungs, removing blood stasis and regulating immune system in Lianhua Qingwen prescription. Studies have confirmed that different doses of Rhodiola rosea do not cause toxic or side effects in the liver, kidney and other tissues of mice, and are very safe.It can be seen that Lianhua Qingwen Capsules are derived from famous prescriptions from three dynasties. The relevant classic prescriptions have been used for thousands of years and are still widely used in clinical practice with good safety.
